Sofia Keim

574 total citations
10 papers, 261 citations indexed

About

Sofia Keim is a scholar working on Psychiatry and Mental health, Neurology and Epidemiology. According to data from OpenAlex, Sofia Keim has authored 10 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Sofia Keim's work include Schizophrenia research and treatment (5 papers), Psychosomatic Disorders and Their Treatments (3 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Sofia Keim is often cited by papers focused on Schizophrenia research and treatment (5 papers), Psychosomatic Disorders and Their Treatments (3 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Sofia Keim collaborates with scholars based in France, Netherlands and Germany. Sofia Keim's co-authors include Paul Bergmans, L. Hargarter, A. Schreiner, Elmārs Rancāns, Eduard Parellada, Bernardo Carpiniello, Yasin Bez, Pierre Vidailhet, Abdullah Bennakhi and Stacey L. House and has published in prestigious journals such as Psychopharmacology, Progress in Neuro-Psychopharmacology and Biological Psychiatry and Clinical Therapeutics.

In The Last Decade

Sofia Keim

10 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Keim France 8 143 64 56 43 36 10 261
Katharina Lau Germany 8 31 0.2× 144 2.3× 23 0.4× 13 0.3× 21 0.6× 12 271
Lijuan Fu China 8 50 0.3× 100 1.6× 5 0.1× 20 0.5× 19 0.5× 21 260
John T. Stutts United States 8 49 0.3× 73 1.1× 26 0.6× 21 0.6× 14 337
Blessed Winston Aruldhas India 9 52 0.4× 19 0.3× 2 0.0× 22 0.5× 6 0.2× 24 251
Caroline Barkholt Kamp Denmark 8 28 0.2× 15 0.2× 6 0.1× 5 0.1× 35 1.0× 32 214
Wen-Pang Su Taiwan 10 22 0.2× 156 2.4× 57 1.3× 11 0.3× 13 371
Bhumika Shah United States 6 30 0.2× 11 0.2× 2 0.0× 57 1.3× 40 1.1× 17 192
Denise Duncan United Kingdom 7 36 0.3× 9 0.1× 4 0.1× 26 0.6× 9 0.3× 15 369
Sanne Kloosterboer Netherlands 11 114 0.8× 5 0.1× 2 0.0× 20 0.5× 21 0.6× 21 265
Pauline Barbeau Canada 5 25 0.2× 45 0.7× 25 0.6× 7 0.2× 6 244

Countries citing papers authored by Sofia Keim

Since Specialization
Citations

This map shows the geographic impact of Sofia Keim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Keim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Keim more than expected).

Fields of papers citing papers by Sofia Keim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Keim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Keim. The network helps show where Sofia Keim may publish in the future.

Co-authorship network of co-authors of Sofia Keim

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Keim. A scholar is included among the top collaborators of Sofia Keim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Keim. Sofia Keim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Robaeys, Geert, Stefan Christensen, Damien Lucidarme, et al.. (2017). Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study. Infectious Diseases and Therapy. 6(2). 265–275. 4 indexed citations
3.
Hassanein, Mohamed, Akram Echtay, Ahmed Hassoun, et al.. (2017). Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS). International Journal of Clinical Practice. 71(10). e12991–e12991. 43 indexed citations
4.
5.
Raziky, Maissa El, Mohamed Gamil, Wahid Doss, et al.. (2016). Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis. Journal of Viral Hepatitis. 24(2). 102–110. 25 indexed citations
6.
Hargarter, L., Paul Bergmans, Sofia Keim, et al.. (2016). Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia. Expert Opinion on Pharmacotherapy. 17(8). 1043–1053. 27 indexed citations
7.
8.
Varannes, Stanislas Bruley des, Renzo Cestari, Κonstantinos Τriantafyllou, et al.. (2014). Classification of adults suffering from typical gastroesophageal reflux disease symptoms: contribution of latent class analysis in a European observational study. BMC Gastroenterology. 14(1). 112–112. 4 indexed citations
9.
Schreiner, A., Paul Bergmans, Sofia Keim, et al.. (2014). A Prospective Flexible-Dose Study of Paliperidone Palmitate in Nonacute But Symptomatic Patients With Schizophrenia Previously Unsuccessfully Treated With Oral Antipsychotic Agents. Clinical Therapeutics. 36(10). 1372–1388.e1. 31 indexed citations
10.
Hargarter, L., Paul Bergmans, Sofia Keim, et al.. (2014). Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 58. 1–7. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharina Lau Breakdown of academic impact, for papers by Lijuan Fu Breakdown of academic impact, for papers by John T. Stutts Breakdown of academic impact, for papers by Blessed Winston Aruldhas Breakdown of academic impact, for papers by Caroline Barkholt Kamp Breakdown of academic impact, for papers by Wen-Pang Su Breakdown of academic impact, for papers by Bhumika Shah Breakdown of academic impact, for papers by Denise Duncan Breakdown of academic impact, for papers by Sanne Kloosterboer Breakdown of academic impact, for papers by Pauline Barbeau
Rankless by CCL
2026